If the central government (central government) can give it to children above 12 years of age, it can be given under ‘Biovotech’ (Kovacin) clinical trial.
On Sunday, the Drug Controller General of India (DCGI) approved the biotech coronavirus vaccine ‘Kovacin’ for emergency use in India and the Cov Institute’s vaccine ‘Kovishield’. Immunization work will start in the country soon. If the central government wants (central government), this vaccine can be given to children above 12 years of age under clinical examination. In fact, DCGI India has licensed Biotech to manufacture and sell the vaccine, which can be given to ’12 year olds or older’.
India Biotech has also tested the vaccine on children aged 12-18 in the second phase. Based on this, DCGI has approved limited use of the vaccine in an emergency in clinical trial mode and has included children 12 years of age or older. However, children were not included in the government’s priority to vaccinate 300 million people.
Private clinics in Brazil show interest in buying 5 million doses of Indian coronavirus vaccine
Let us tell you that Corona is declining in India. According to the data released by the Ministry of Health this (Monday) morning, 1 new case of CVD-19, 504 cases have been found in the last 24 hours and 214 patients have died during this period. The total number of infected in the country is 1,03,40,469 69 so far 99,46,867 patients have been cured. 1,49,649 people died. The number of active cases of corona is 2,43,953.
Video: Vaccine politics has intensified, with many Congress leaders expressing doubts after the SP